Peter Harrison CEO Bioventix (BVXP)
ShareSoc Richmond 6.6.16
A succinct presentation to understand what BVXP do.
• The product
• Revenue streams
• Stickiness of revenue
• Timelines to develop revenue streams
• Barriers to entry
• Threats
• The future
A sense of the culture of the company
The journey of the historic research that led to current products.
The pipeline of future products.
Peter Harrison is a 12% shareholder, Miton 14.5% and other institutional holders
Q&A at 38:55, with questions around possible threats covering:
• Impact of loss of NT proBNP, and replacement of revenues by Troponin
• Technological threats
• Time it’s taken to get Treponin to market
• The future of company
• Personalise medicine
• Collaborations with other organisations
Presentation slides can be viewed here.
PIWORLD provides investors with the latest news and insight about listed companies and their management through either live or recorded investor presentations, management interviews, Capital Market Days and corporate overviews, together with interviews with leading fund managers or esteemed private investors in the small cap world.
PIWORLD delivers high quality audio and video content to present anything from full-year & interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.
